Explore Charles River Boisbriand
Formerly known as AccelLAB, the scientists at our Boisbriand facility have been tackling the challenges of device development for decades, delivering personalized service and scientific excellence that gets products across the finish line.
Take a closer look.
Charles River Laboratories’ Boisbriand facility is located just minutes outside Montreal, Canada and offers a robust portfolio of medical device preclinical testing capabilities. See what's waiting for your program.
Streamline Your Medical Device Development with Specialized Capabilities
From cardiac and vascular to orthopedic models and everything in between, you’ll find exactly what you need for program success at Boisbriand.
Meet Your Medical Device Safety Team
Commitment to scientific excellence. Command of regulatory considerations. Dedication to your programs. Get all of this and more when you partner with our experts.
François Bergeron, M.Sc.
Director of Business Development
As a trilingual senior BD strategist and deal-maker, with over 30 years of experience in the health sector within small, medium and large companies, Francois has successfully realigned business strategies and concluded significant business partnerships on four continents.
Business Development Director
Amy Stricker-Hume has been in the preclinical CRO environment since 2001, working with innovators of medical devices and combination products from early feasibility through GLP safety and post-market assessments.
Michel Assad, PhD
Executive Orthopedics and Biomaterials Director
Dr. Michel Assad is an accomplished biomaterials scientist with over 25 years of experience in preclinical research and product development. His scientific expertise includes biocompatibility, soft and hard tissue integration, in addition to safety, efficacy and performance evaluation of various orthopedic biomaterials and biologics.
Gerald Poeltl, MBA
Business Development Director
Gerald is a seasoned business development professional with more than 10 years of experience in senior business development and site management roles at mid-sized and global CROs. In his role he builds the bridge between science and market for medical technologies.
Louis-Georges Guy, PhD
Senior Director of Science
Dr. Guy established the scientific program for the preclinical evaluation of medical devices in the fields of cardiology, ENT, orthopedics, and others. As an expert in bioabsorbable scaffolds, he has authored many articles, presented for sponsors in scientific meetings, and was invited as preclinical expert at a workshop at the FDA and a biodegradable metal symposium.
Nancy Doyle is a Scientific Advisor in Medical Devices, with almost 25 years of experience in the conduct and design of studies in cartilage/bone toxicology and a variety of medical devices with a good understanding of the different related guidelines. She has authored and co-authored several publications in peer reviewed journals.
Designing Studies for MDR-Compliant Medical Devices with Risk-Based Management
By carefully integrating risk management into preclinical animal studies, you’ll gain an advantage over competitors by being able to proactively anticipate any risks that could prevent your medical device from reaching the market.
Watch the Webinar